caa a22 4500 378923048 CHVBK 20180305123610.0 cr unu---uuuuu 161128e20040101xx s 000 0 eng 10.1351/pac200476030477 doi (NATIONALLICENCE)gruyter-10.1351/pac200476030477 Synthetic applications of planar chiral cationic η3-allylmolybdenum complexes [Elektronische Daten] [P. Kocienski, Richard Bell, Elyse Bourque, J. A. Christopher, John Cooksey, Andrew Gunn, Alexander Kuhl, Y. Li, S. Uppal, Josephine Yuen] The synthesis of planar chiral η3-allylmolybdenum complexes is described together with some examples of the nucleophilic addition of organocopper(I) reagents. © 2013 Walter de Gruyter GmbH, Berlin/Boston Kocienski P. Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut Bell Richard Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut Bourque Elyse Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut Christopher J. A. Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut Cooksey John Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut Gunn Andrew Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut Kuhl Alexander Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut Li Y. Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut Uppal S. Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut Yuen Josephine Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut Pure and Applied Chemistry De Gruyter 76/3(2004-01-01), 477-494 0033-4545 76:3<477 2004 76 pac https://doi.org/10.1351/pac200476030477 text/html Onlinezugriff via DOI 1 research article jats NATIONALLICENCE 856 40 https://doi.org/10.1351/pac200476030477 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Kocienski P. Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut NATIONALLICENCE 700 1- Bell Richard Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut NATIONALLICENCE 700 1- Bourque Elyse Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut NATIONALLICENCE 700 1- Christopher J. A. Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut NATIONALLICENCE 700 1- Cooksey John Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut NATIONALLICENCE 700 1- Gunn Andrew Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut NATIONALLICENCE 700 1- Kuhl Alexander Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut NATIONALLICENCE 700 1- Li Y. Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut NATIONALLICENCE 700 1- Uppal S. Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut NATIONALLICENCE 700 1- Yuen Josephine Department of Chemistry, Leeds University, Leeds LS2 9JT, UK; Department of Chemistry, Glasgow University, Glasgow G12 8QQ, UK; GlaxoSmithKline Research and Development, Medicines Research Centre, Stevenage, Hertfordshire SG1 2NY, UK aut NATIONALLICENCE 773 0- Pure and Applied Chemistry De Gruyter 76/3(2004-01-01), 477-494 0033-4545 76:3<477 2004 76 pac CC0 http://creativecommons.org/publicdomain/zero/1.0 nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-gruyter